Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 8, 2012, Pages 1035-1043

  Sisti, Antonio De ^a   Márquez, Manlio F ^b   Tonet, Joelci ^a   Bonny, Aim ^a,c   Frank, Robert ^a   Hidden Lucet, Fraņoise ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c Saint Camille Hospital   (France)

Author keywords

atrial fibrillation; cardiac pacing; heart failure; implantable cardioverter defibrillator; mortality; right ventricular pacing

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ATRIOVENTRICULAR BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE PACING; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE PACING; HUMAN; MEDLINE; REVIEW; SINUS NODE DYSFUNCTION;

ALGORITHMS; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; HEART FAILURE; HUMANS; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 84864704703     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03371.x     Document Type: Review

References (49)

1. Anter E, Jessup M, Callans DJ,. Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic. Circulation 2009; 119: 2516-2525.
2. Tops LF, Schalij MJ, Bax JJ,. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol 2009; 54: 764-776.
3. Varma N,. Left ventricular conduction delays induced by right ventricular apical pacing: Effect of left ventricular dysfunction and bundle branch block. J Cardiovasc Electrophysiol 2008; 19: 114-122.
4. Lin YS, Guo GB, Chen YL, Tsai TH, Pan KL, Liu WH, Chen MC,. Atrial enlargement in symptomatic heart block patients with preserved left ventricular function: Possibly related to atrioventricular dyssynchrony. Int J Cardiol 2011; 148: 280-284.
5. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK,. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350: 1210-1216.
6. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA,.; Mode Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107: 2932-2937.
7. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, et al.,; The DAVID trial investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The dual chamber and VVI implantable defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-3123.
8. Olshansky B, Day J, Moore S, Gering L, Rosenbaum M, McGuire M, Brown S, et al,. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (inhibition of unnecessary RV pacing with AVSH in ICDs study). Circulation 2007; 115: 9-16.
9. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, et al., Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007; 357: 1000-1008.
10. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA, et al.,; Pacemaker Selection in the Elderly Investigators. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338: 1097-1104.
11. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, et al.,; Canadian Trial of Physiologic Pacing Investigators. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med. 2000; 342: 1385-1391.
12. Toff WD, Camm AJ, Skehan JD,; United Kingdom Pacing and Cardiovascular Events Trial (UKPACE) Investigators. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005; 353: 145-155.
13. Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA, Lee KL, et al,. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: Meta-analysis of randomized trials, using individual patient data. Circulation 2006; 114: 11-17.
14. Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK,. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcome. J Am Coll Cardiol 2003; 42: 614-623.
15. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, et al,. Ventricular pacing or dual-chamber pacing for sinus node dysfunction. N Engl J Med 2002; 346: 1854-1862.
16. Nielsen JC, Pedersen AK, Mortensen PT, Andersen HR,. Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome. Europace 1999; 1: 113-120.
17. Murakami Y, Tsuboi N, Inden Y, Yoshida Y, Murohara T, Ihara Z, Takami M,. Difference in percentage of ventricular pacing between two algorithms for minimizing ventricular pacing: Results of the IDEAL-RVP (identify the best algorithm for reducing unnecessary ventricular pacing) study. Europace 2010; 12: 96-102.
18. Pioger G, Leny G, Nitzsché R, Ripart A,. AAI SafeR limits ventricular pacing in unselected patients. Pacing Clin Electrophysiol 2007; 30 (Suppl 1): S66-S70.
19. Karpawich PP, Rabah R, Haas JE,. Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block. Pacing Clin Electrophysiol 1999; 22: 1372-1377.
20. Tantengco MV, Thomas RL, Karpawich PP,. Left ventricular dysfunction after long-term right ventricular apical pacing in the young. J Am Coll Cardiol 2001; 37: 2093-2100.
21. Thambo JB, Bordachar P, Garrigue S, Lafitte S, Sanders P, Reuter S, Girardot R, et al,. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation 2004; 110: 3766-3772.
22. Albertsen AE, Nielsen JC, Poulsen SH, Mortensen PT, Pedersen AK, Hansen PS, Jensen HK, et al,. DDD(R)-pacing, but not AAI(R)-pacing induces left ventricular desynchronization in patients with sick sinus syndrome: Tissue-doppler and 3D echocardiographic evaluation in a randomized controlled comparison. Europace 2008; 10: 127-133.
23. Sagar S, Shen WK, Asirvatham SJ, Cha YM, Espinosa RE, Friedman PA, Hodge DO, et al,. Effect of long-term right ventricular pacing in young adults with structurally normal heart. Circulation 2010; 121: 1698-1705.
24. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, Pires LA, et al,. Left ventricular based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005; 16: 1160-1165.
25. Brignole M, Botto G, Mont L, Iacopino S, De Marchi G, Oddone D, Luzi M, et al,. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: A randomized trial. Eur Heart J 2011; 32: 2420-2429.
26. Tops LF, Schalij MJ, Holman ER, van Erven L, van der Wall EE, Bax JJ,. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006; 48: 1642-1648.
27. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, Langberg JJ, et al,. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002; 39: 1258-1263.
28. Kindermann M, Hennen B, Jung J, Geisel J, Bohm M, Frohlig G,. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: The homburg biventricular pacing evaluation (HOBIPACE). J Am Coll Cardiol 2006; 47: 1927-1937.
29. Yu CM, Chan JY, Zhang Q, Omar R, Yip GW, Hussin A, Fang F, et al,. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009; 361: 2123-2134.
30. Chan JY, Fang F, Zhang Q, Fung JW, Razali O, Azlan H, Lam KH, et al,. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 2011; 32: 2533-2540.
31. Albertsen AE, Mortensen PT, Jensen HK, Poulsen SH, Egeblad H, Nielsen JC,. Adverse effect of right ventricular pacing prevented by biventricular pacing during long-term follow-up: A randomized comparison. Eur J Echocardiogr 2011; 12: 767-772.
32. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, et al.,; ESC Committee for practice guidelines. 2010 Focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010; 12: 1526-1536.
33. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, et al,. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-408.
34. Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, McNitt S, Andrews M, et al,. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol 2005; 16: 359-365.
35. Sharma A, Rizo-Patron C, Hallstrom AP, O'Neill GP, Rothbart S, Martins JB, Roelke M, et al,. Percent of right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005; 2: 830-834.
36. Wilkoff BL, Kudenchuk PJ, Buxton AE, Sharma A, Cook JR, Bhandari AK, Biehl M, et al,. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J Am Coll Cardiol 2009; 53: 872-880.
37. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, et al,. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: An extended 8-year follow-up study of the multicenter automatic defibrillator implantation trial II. Circulation 2010; 122: 1265-1271.
38. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS,.; Multicenter automatic defibrillator implantation trial (MADIT) II Investigators. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 2006; 113: 2810-2817.
39. Olshansky B, Day JD, Lerew DR, Brown S, Stolen KQ,; INTRINSIC RV Study Investigators. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators. Heart Rhythm 2007; 4: 886-891.
40. Sweeney MO, Ellenbogen KA, Tang AS, Whellan D, Mortensen PT, Giraldi F, Sandler DA, et al.,; Managed Ventricular Pacing Versus VVI 40 Pacing Trial Investigators. Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients. Heart Rhythm 2010; 7: 1552-1560.
41. Melzer C, Bohm M, Bondke HJ, Combs W, Baumann G, Theres H,. Chronotropic incompetence in patients with an implantable cardioverter defibrillator: Prevalence and predicting factors. Pacing Clin Electrophysiol 2005; 28: 1025-1031.
42. Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R,. Cost advantages of dual chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol 2005; 46: 850-857.
43. Tonet J, Frank R, Fontaine G, Grosgogeat Y,. Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia. Pacing Clin Electrophysiol 1988; 11 (11 Pt 2): 1984-1989.
44. Nishimura RA, Hayes DL, Holmes DR, Tajik AJ,. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: An acute Doppler and catheterization study. J Am Coll Cardiol 1995; 25: 281-288.
45. Sweeney MO, Ellenbogen KA, Tang ASL, Johnson J, Belk P, Sheldon T,. Severe atrioventricular decoupling, uncoupling and ventriculoatrial coupling during enhanced atrial pacing: Incidence, mechanisms and implications for minimizing right ventricular pacing in ICD patients. J Cardiovasc Electrophysiol 2008; 19: 1175-1180.
46. den Dulk K, Lindemans FW, Brugada P, Smeets JLRM, Wellens HJJ,. Pacemaker syndrome with AAI rate variable pacing: Importance of atrioventricular conduction properties, medications, and pacemaker programmability. Pacing Clin Electrophysiol 1988; 11: 1226-1233.
47. Luceri RM, Brownstein SL, Vardeman L, Goldstein S,. PR interval behavior during exercise, implications for physiologic pacemakers. Pacing Clin Electrophysiol 1990; 13: 1719-1723.
48. Fung JW, Yu CM,. Should we switch to RVOT pacing for all now? Not yet. J Cardiovasc Electrophysiol 2010; 21 (10): 1120-1126.
49. Shimony A, Eisenberg MJ, Filion KB, Amit G,. Beneficial effects of right ventricular non-apical vs. apical pacing: A systematic review and meta-analysis of randomized-controlled trials. Europace March 2012; 4: 81-91.